A webinar presented by ZeptoMetrix®, an Antylia Scientific company.
Since the onset of the SARS-CoV-2 pandemic, many clinical labs acquired new molecular diagnostic platforms to reduce send out costs and expedite test results. While COVID-19 testing is still a priority, many laboratories are faced with the question: what next? How can we get the most out of our new platforms while juggling supply chain issues and limited staffing?
This webinar, presented by ZeptoMetrix, will provide you with insight into the current infectious disease testing landscape and highlight a path forward for clinical laboratories that ensures accurate infectious disease monitoring and result generation.
What you will learn
- How clinical labs are expanding beyond COVID-19 testing with limited resources
- How to get the most out of your laboratory quality controls
- How ZeptoMetrix can help laboratories expand their testing menus and move forward after COVID-19
About the presenter
Lead Technical Support Specialist
View the webinar below
Learn more about Zeptometrix.